Hikma FDA Tuesday, February 28, 1995 0.00 Neutral

FDA Approves ACETAZOLAMIDE — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. secured FDA approval for Intravenous Acetazolamide Sodium in 1995, expanding its generic portfolio into the IV segment and positioning the company to capture market share in the therapeutic category.

View original filing at SEC.gov →

AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day